Klabax (Clarithromycin)

Clarithromycin inhibits bacterial protein synthesis by binding to the 50S ribosomal subunit, blocking the translocation step of peptide chain elongation. This action stops bacterial growth and also provides anti‑inflammatory effects that can help resolve respiratory infections.

The dosage of Klabax is determined by the prescribing clinician based on the specific infection, patient age, weight, renal and hepatic function, and local treatment guidelines. Patients should follow the exact regimen provided by their healthcare professional.

Safety data for clarithromycin in pregnancy and lactation are limited. The product is classified as pregnancy category unknown, so it should only be used when the potential benefit justifies any potential risk. Women who are pregnant, planning pregnancy, or breastfeeding should discuss alternatives with their doctor.

To order Klabax, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Compared with azithromycin or erythromycin, clarithromycin (Klabax) often offers a broader spectrum against certain Gram‑positive organisms and better gastric stability. It may have a higher potential for drug‑drug interactions due to CYP3A4 inhibition, so clinicians must review concomitant medications carefully.

Klabax tablets should be stored at ambient temperature, below 25 °C, in the original packaging to protect them from moisture and light. Keep the product out of reach of children and do not use it after the expiry date printed on the label.

Klabax is taken orally with a full glass of water. It may be taken with or without food, but taking it with meals can reduce gastrointestinal upset. The tablet should be swallowed whole and not crushed or chewed unless specifically instructed by a healthcare provider.

Serious risks include Clostridioides difficile‑associated colitis, hepatotoxicity (elevated liver enzymes or jaundice), and QT‑interval prolongation that can lead to life‑threatening cardiac arrhythmias. Patients should seek immediate medical attention if they experience severe diarrhea, yellowing of the skin or eyes, or irregular heartbeats.

Klabax should be avoided in individuals with a known hypersensitivity to clarithromycin or other macrolides, in patients with a history of significant QT prolongation, and in those taking medications that have a major interaction risk such as cisapride or ergot alkaloids. Clinicians must also assess liver and kidney function before initiating therapy.